News

Zoom Communications Analysts Adjust Future Earnings Projections

Zoom Communications Analysts Adjust Future Earnings Projections

Analysts Adjust Zoom Communications Earnings Expectations

Zoom Communications Inc (NASDAQ: ZM) is preparing to reveal its financial results for the fourth quarter shortly. Industry analysts predict that the company will report earnings of $1.35 per share, a slight decrease from the $1.42 per share reported in the same quarter last year. Furthermore, revenue is anticipated to reach approximately $1.19 billion, showcasing modest growth from the previous year's $1.15 billion.

Recent Performance Highlights

In the last quarterly report released on November 25, Zoom achieved a revenue of $1.18 billion, beating analysts' expectations of $1.16 billion. The company also reported adjusted earnings of $1.38 per share, surpassing the anticipated $1.31 per share. This performance highlights Zoom's ability to navigate challenging market conditions effectively.

Current Market Reaction

Despite the optimistic outlook, Zoom's stock experienced a minor decline, falling 1.1% to close at $82.50 on a recent trading day. Investors are keenly watching how these earnings will influence the stock's movement in the upcoming days.

Analysts' Ratings and Predictions

Analysts have varying perspectives on Zoom's stock. Citigroup analyst Tyler Radke has maintained a neutral stance but slightly reduced the price target from $86 to $85. Analysts at Cantor Fitzgerald initiated their coverage with a neutral rating and a price target of $87, while Wells Fargo upgraded its rating from Underweight to Equal-Weight, lifting the price target from $70 to $85. Additionally, Morgan Stanley's Meta Marshall raised the price target from $86 to $96, and Rosenblatt’s Catharine Trebnick increased her price target from $78 to $95, maintaining a buy rating. These adjustments reflect the analysts’ responses to Zoom’s trajectory and competitive landscape.

What the Changes Mean for Investors

With changes in ratings and price targets, investors are encouraged to analyze current trends and projections. The upgrades from respected analysts may indicate a growing confidence in the company's ability to perform despite market fluctuations. As Zoom gears up for its earnings report, investors should consider these insights while making investment decisions around ZM stock.

Frequently Asked Questions

What financial results is Zoom expected to report?

Analysts anticipate Zoom will report earnings of $1.35 per share and revenue of approximately $1.19 billion for the fourth quarter.

How did Zoom perform in the last quarter?

In the last quarterly report, Zoom reported revenue of $1.18 billion and adjusted earnings of $1.38 per share, both exceeding market expectations.

What is the current stock price of Zoom Communications?

As of recent trading sessions, Zoom's stock is priced at $82.50.

Are analysts optimistic about Zoom's future?

Yes, several analysts have recently adjusted their ratings and price targets for Zoom, reflecting a positive outlook despite slight downward adjustments in some cases.

How can I keep up with Zoom's market performance?

Investors can keep up with Zoom's market performance by following earnings reports, analyst ratings, and market trends related to its financial and operational developments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PNU and Cellenkos Team Up for Biotech Advancements

Updated Category News Views 52

Paving New Paths in Biotech Collaboration When a university and a biotech company shake hands to bolster their capabilities in the ever-evolving field of clinical trials and cell and gene therapies, investors and industry buffs alike should perk up. The College of Medicine at Princess Nourah bint Abdulrahman University (PNU) has just inked a Memorandum of Understanding...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 497

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Nutex Health Scores Top Workplace Honor in 2026

Updated Category News Views 95

Nutex Health: Accolades and Aspirations Nutex Health just snagged something pretty noteworthy: They've been crowned a 2026 Houston Top Workplace by the Houston Chronicle. Now, before you start throwing confetti, let's chew on what this really means. It's no small potatoes, folks. We're talking employee respect and satisfaction measured by Energage’s surveys. It's proof...

Continue Reading
Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 199

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 136

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 164

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 196

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 207

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 7

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 172

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading

Top 5 Most Recently Viewed Articles

Object Management Group Seeks Input on New SPECTRA-CSV Spec

Updated Category News Views 255

Object Management Group's Latest Initiative for Cybersecurity Standards In a significant move towards enhancing cybersecurity measures, Object Management Group (OMG) has announced the public release of the SPECTRA-CSV specification. This document is now open for comments from interested stakeholders, as part of OMG's ongoing mission to develop timely and effective...

Continue Reading
Dizal's Innovative Treatments in Hematology Show Promising Results

Updated Category News Views 172

Dizal's Innovations in Hematology Treatment At a recent medical meeting, Dizal, a biopharmaceutical company dedicated to developing groundbreaking therapies for cancer and immunological diseases, shared compelling new data from its hematology drug portfolio. Investors and healthcare providers alike took note of the latest findings on golidocitinib and birelentinib,...

Continue Reading
Transforming Workplace Wellness with Rejuvenation Stations

Updated Category News Views 116

Rejuvenation Stations Revolutionizing Workplace Wellness In today's fast-paced world, workplace stress has become a significant concern for many, especially among healthcare professionals. The innovative solution offered by Rejuvenation Stations provides a refreshing break to help individuals manage their stress effectively. These wellness pods and kiosks are specifically...

Continue Reading
Watercrest Richmond Welcomes The New Year with Celebration

Updated Category News Views 155

Watercrest Richmond Celebrates the New Year in Style The residents and associates of Watercrest Richmond Assisted Living and Memory Care welcomed the New Year with a joyful celebration. This event marked not only a new calendar year but also the vibrant community spirit that thrives at this senior living facility. A Memorable New Year's Celebration The New Year's...

Continue Reading
Pinnacle Fertility Welcomes Dr. Si Won Lee to Enhance Care

Updated Category News Views 261

Pinnacle Fertility Virginia Enhances Patient Care with New Physician Pinnacle Fertility Virginia is thrilled to announce a significant enhancement to its patient care team with the addition of Dr. Si Won Lee, an internationally trained reproductive endocrinologist. This new appointment marks a notable expansion for the clinic, which has long been recognized as a leader in...

Continue Reading